Neurotrophic factors are considered as part of the therapeutic strategy for neurological
disorders like dementia, stroke and traumatic brain injury. Cerebrolysin is a neuropeptide …

Alzheimer's disease (AD) is the most common neurocognitive disorder and a global health
problem. The prevalence of AD is growing dramatically, especially in low‐and middle …

Cerebrolysin (EBEWE Arzneimittel, Austria, Europe) is a widely used drug relieving the
symptoms of a variety of neurological disorders, particularly of neurodegenerative dementia …

Cerebrolysin (CBL) is a peptide mixture with neurotrophic effects that might reduce the
neurodegenerative alterations in Alzheimer's disease (AD). We have previously shown that …

Cerebrolysin is a peptide mixture with neurotrophic effects that might reduce the
neurodegenerative pathology in Alzheimer's disease (AD). We have previously shown in an …

Among the 23 members of the fibroblast growth factor (FGF) family, FGF-2 is the most
abundant one in the central nervous system. Its impact on neural cells has been profoundly …

Alzheimer's disease (AD) is characterized by degeneration of neocortex, limbic system, and
basal forebrain, accompanied by accumulation of amyloid‐β and tangle formation …

Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by
progressive memory deficits and other cognitive disturbances. Neuropathologically, AD is …

Apoptosis is a prerequisite to model the developing nervous system. However, an increased
rate of cell death in the adult nervous system underlies neurodegenerative disease and is a …

Nerve growth factor (NGF) and its precursor form, proNGF, are critical for neuronal survival
and cognitive function. In the brain, proNGF is the only detectable form of NGF …